Management of Pneumonia in the Philippines
The management of pneumonia in the Philippines should follow a structured approach focusing on appropriate antibiotic therapy, supportive care, and monitoring based on severity assessment.
Assessment and Classification
- Pneumonia severity should be assessed using clinical parameters including respiratory rate, oxygen saturation, mental status, and presence of comorbidities 1
- Classify pneumonia as mild (suitable for outpatient management), non-severe (requiring hospitalization), or severe (requiring intensive care) 1
- Hypoxemia (SaO₂ <92% or PaO₂ <8 kPa) is a critical indicator of severe pneumonia requiring hospitalization 1
- Bilateral or multilobe involvement on chest radiograph indicates higher severity 1
Antibiotic Management
For Outpatient (Mild) Pneumonia
- Amoxicillin remains the preferred first-line agent at a higher dose than previously recommended 1
- A macrolide (erythromycin or clarithromycin) is recommended as an alternative for patients with penicillin hypersensitivity 1
- Azithromycin can be considered as an effective alternative with a shorter treatment course (500 mg on day 1, plus 250 mg/day on days 2-5) 2
For Hospitalized (Non-Severe) Pneumonia
- Combined oral therapy with amoxicillin and a macrolide (erythromycin or clarithromycin) is preferred 1
- Most patients can be adequately treated with oral antibiotics rather than intravenous formulations 1
- For patients unable to take oral medications, intravenous options include ceftriaxone or cefotaxime 1
For Severe Pneumonia (ICU)
- Combination therapy with a β-lactam plus either a macrolide or a respiratory fluoroquinolone is recommended 1, 3
- For suspected Pseudomonas infection, an anti-pseudomonal β-lactam (piperacillin/tazobactam) plus either an anti-pseudomonal fluoroquinolone or an aminoglycoside is recommended 4, 5
- Patients should be managed by specialists with appropriate training in intensive care and respiratory medicine 1
Duration of Antibiotic Treatment
- For non-severe and uncomplicated pneumonia, 7 days of appropriate antibiotics is typically sufficient 6
- For severe pneumonia without a defined pathogen, 10 days of treatment is recommended 6
- Extend treatment to 14-21 days for Legionella, staphylococcal, or Gram-negative enteric bacilli pneumonia 6
Supportive Care
- All patients should receive appropriate oxygen therapy with monitoring of oxygen saturations to maintain SaO₂ >92% 1
- Assess for volume depletion and provide intravenous fluids if needed 1
- Provide nutritional support in cases of prolonged illness 1
- Monitor temperature, respiratory rate, pulse, blood pressure, mental status, and oxygen saturation at least twice daily 1
- For outpatients, advise rest, adequate hydration, and simple analgesia such as paracetamol for pleuritic pain 1
Monitoring and Follow-up
- Review patients in the community with pneumonia after 48 hours or earlier if clinically indicated 1
- The CRP level should be remeasured and chest radiograph repeated in patients who are not progressing satisfactorily 1
- Clinical review should be arranged for all patients at around 6 weeks post-treatment 1
- A chest radiograph should be arranged at follow-up for patients with persistent symptoms or at higher risk of underlying malignancy (especially smokers and those over 50 years) 1
Special Considerations
- Bronchoscopy should be considered in patients with persisting signs, symptoms, and radiological abnormalities about 6 weeks after completing treatment 1, 6
- For patients with pre-existing chronic obstructive pulmonary disease complicated by ventilatory failure, oxygen therapy should be guided by repeated arterial blood gas measurements 1
- In patients improving clinically, radiological improvement often lags behind clinical recovery and does not necessarily require additional investigation 1
Common Pitfalls to Avoid
- Delaying antibiotic administration in severe cases - antibiotics should be given immediately when pneumonia is considered life-threatening 1
- Assuming radiological improvement will match clinical improvement - radiological changes often lag behind clinical recovery 6
- Failing to consider resistant organisms or atypical pathogens not covered by initial therapy 1
- Inadequate oxygen monitoring and supplementation - maintain SaO₂ >92% with appropriate oxygen therapy 1, 3